GB0914767D0 - Compound - Google Patents
CompoundInfo
- Publication number
- GB0914767D0 GB0914767D0 GBGB0914767.9A GB0914767A GB0914767D0 GB 0914767 D0 GB0914767 D0 GB 0914767D0 GB 0914767 A GB0914767 A GB 0914767A GB 0914767 D0 GB0914767 D0 GB 0914767D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0914767.9A GB0914767D0 (en) | 2009-08-24 | 2009-08-24 | Compound |
| EP10750154.6A EP2470512B1 (en) | 2009-08-24 | 2010-08-23 | Aromatase inhibitor |
| CN201080037827.XA CN102596919B (zh) | 2009-08-24 | 2010-08-23 | 芳香酶抑制剂 |
| JP2012526125A JP5828839B2 (ja) | 2009-08-24 | 2010-08-23 | アロマターゼ阻害剤 |
| RU2012111119/04A RU2572244C2 (ru) | 2009-08-24 | 2010-08-23 | Ингибиторы ароматазы |
| PCT/GB2010/051391 WO2011023989A1 (en) | 2009-08-24 | 2010-08-23 | Aromatase inhibitor |
| US13/392,206 US8846737B2 (en) | 2009-08-24 | 2010-08-23 | Compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0914767.9A GB0914767D0 (en) | 2009-08-24 | 2009-08-24 | Compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0914767D0 true GB0914767D0 (en) | 2009-09-30 |
Family
ID=41171838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0914767.9A Ceased GB0914767D0 (en) | 2009-08-24 | 2009-08-24 | Compound |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8846737B2 (enExample) |
| EP (1) | EP2470512B1 (enExample) |
| JP (1) | JP5828839B2 (enExample) |
| CN (1) | CN102596919B (enExample) |
| GB (1) | GB0914767D0 (enExample) |
| RU (1) | RU2572244C2 (enExample) |
| WO (1) | WO2011023989A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3089966B1 (en) * | 2013-12-31 | 2020-10-21 | EstryX Pharma Limited | New substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase |
| DE102017116299A1 (de) | 2017-07-19 | 2019-01-24 | Huf Hülsbeck & Fürst Gmbh & Co. Kg | Verfahren zum Zuordnen einer Reifendrucküberwachungseinheit zu einer Radposition eines Fahrzeugs |
| IL273428B2 (en) | 2017-09-22 | 2023-09-01 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
| CN111225915B (zh) | 2017-10-18 | 2023-03-07 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的咪唑并吡啶化合物 |
| BR112020008851A2 (pt) | 2017-11-06 | 2020-10-20 | Jubilant Prodel LLC | composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas |
| JP7368369B2 (ja) | 2017-11-24 | 2023-10-24 | ジュビラント・エピスクライブ・エルエルシー | Ｐｒｍｔ５阻害剤としてのヘテロ環式化合物 |
| EP3728207B1 (en) | 2017-12-21 | 2023-02-01 | Ribon Therapeutics Inc. | Quinazolinones as parp14 inhibitors |
| JP7279063B6 (ja) | 2018-03-13 | 2024-02-15 | ジュビラント プローデル エルエルシー | Ｐｄ１／ｐｄ－ｌ１相互作用／活性化の阻害剤としての二環式化合物 |
| PL239999B1 (pl) * | 2018-06-18 | 2022-02-07 | Politechnika Gdanska | A midosiarczanowe pochodne 4-(1-fenylo-1H-[1,2,3]triazol- -4-ylo)-fenolu, ich zastosowanie medyczne i diagnostyczne, oraz sposób otrzymywania amidosiarczanowych pochodnych 4-(1-fenylo- 1H-[1,2,3]triazol-4-ylo)-fenolu |
| CN113387894B (zh) * | 2021-06-22 | 2023-02-24 | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 1-n-苯乙腈基氨基-三氮唑和嘧啶衍生物及其制备方法和应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| GB9003939D0 (en) | 1990-02-21 | 1990-04-18 | Imperial College | Sulphatase inhibitors |
| TW210334B (enExample) * | 1990-12-12 | 1993-08-01 | Ciba Geigy Ag | |
| CH683151A5 (de) | 1991-04-24 | 1994-01-31 | Ciba Geigy Ag | Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus. |
| GB9118478D0 (en) | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
| GB9118465D0 (en) | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
| AU665569B2 (en) | 1991-09-02 | 1996-01-11 | Yamanouchi Pharmaceutical Co., Ltd. | Triazolylated tertiary amine compound or salt thereof |
| GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
| GB9422777D0 (en) | 1994-11-11 | 1995-01-04 | Imperial College | Assay |
| US5723315A (en) | 1996-08-23 | 1998-03-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| EP0968182B1 (en) | 1996-08-07 | 2004-05-06 | Darwin Discovery Limited | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| EP0963377B1 (en) | 1996-08-30 | 2009-03-04 | Human Genome Sciences, Inc. | Interleukin-19 |
| US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| WO1998013348A1 (en) | 1996-09-25 | 1998-04-02 | Ss Pharmaceutical Co., Ltd. | Substituted vinylpyridine derivatives and drugs containing the same |
| US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| AU2958099A (en) | 1998-03-26 | 1999-10-18 | Kyowa Hakko Kogyo Co. Ltd. | Method for searching steroid sulfatase inhibitors |
| GB9807779D0 (en) | 1998-04-09 | 1998-06-10 | Ciba Geigy Ag | Organic compounds |
| US20020019527A1 (en) * | 2000-04-27 | 2002-02-14 | Wei-Bo Wang | Substituted phenyl farnesyltransferase inhibitors |
| CA2464770C (en) * | 2001-11-21 | 2011-08-16 | Sterix Limited | Compound |
| US6737433B1 (en) * | 2002-12-16 | 2004-05-18 | Laboratoire Theramex | 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them |
| EP1544195A1 (en) | 2003-12-15 | 2005-06-22 | Laboratoire Theramex | 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them |
| KR20060123186A (ko) * | 2003-12-15 | 2006-12-01 | 라보라뚜와르 떼라멕스 | 1-엔-페닐-아미노-1에이치-이미다졸 유도체 및 이들을포함하는 약학적 조성물 |
| GB0411562D0 (en) | 2004-05-24 | 2004-06-23 | Sterix Ltd | Compound |
| KR20090026345A (ko) * | 2006-06-22 | 2009-03-12 | 노파르티스 아게 | 아로마타제 억제제의 서방형 제제 |
-
2009
- 2009-08-24 GB GBGB0914767.9A patent/GB0914767D0/en not_active Ceased
-
2010
- 2010-08-23 US US13/392,206 patent/US8846737B2/en active Active
- 2010-08-23 WO PCT/GB2010/051391 patent/WO2011023989A1/en not_active Ceased
- 2010-08-23 JP JP2012526125A patent/JP5828839B2/ja not_active Expired - Fee Related
- 2010-08-23 CN CN201080037827.XA patent/CN102596919B/zh not_active Expired - Fee Related
- 2010-08-23 EP EP10750154.6A patent/EP2470512B1/en active Active
- 2010-08-23 RU RU2012111119/04A patent/RU2572244C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2572244C2 (ru) | 2016-01-10 |
| RU2012111119A (ru) | 2013-10-10 |
| CN102596919B (zh) | 2015-11-25 |
| US20120238550A1 (en) | 2012-09-20 |
| JP2013502451A (ja) | 2013-01-24 |
| CN102596919A (zh) | 2012-07-18 |
| US8846737B2 (en) | 2014-09-30 |
| EP2470512B1 (en) | 2018-05-02 |
| JP5828839B2 (ja) | 2015-12-09 |
| WO2011023989A1 (en) | 2011-03-03 |
| EP2470512A1 (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2423182A4 (en) | DIACYLETHYLENEDIAMINE COMPOUND | |
| GB0907425D0 (en) | Compounds | |
| EP2393493A4 (en) | LINKS | |
| GB0903759D0 (en) | Compound | |
| GB0907515D0 (en) | Compounds | |
| GB0914767D0 (en) | Compound | |
| GB0905641D0 (en) | Compounds | |
| GB0909671D0 (en) | Compounds | |
| GB0909213D0 (en) | Compound | |
| EP2487178A4 (en) | PYRAZOLOTHIAZOLVERBINDUNG | |
| GB0915519D0 (en) | Ntithrombotic compounds | |
| GB0909672D0 (en) | Compounds | |
| AP2909A (en) | Pyrazinoisoquinoline Compounds | |
| GB0914883D0 (en) | Compound | |
| EP2443115A4 (en) | COMPOUNDS | |
| GB0910692D0 (en) | Compound | |
| GB0906821D0 (en) | Compound | |
| GB0901976D0 (en) | Compound | |
| GB0917460D0 (en) | Compound | |
| GB0922714D0 (en) | Compound | |
| GB0922003D0 (en) | Compound | |
| GB0916603D0 (en) | Compound | |
| GB0907825D0 (en) | Novel compound | |
| GB0900456D0 (en) | Compounds | |
| GB0905057D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |